1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Autoimmune Disease Drug Market
3.2. Opportunities in the Autoimmune Disease Drug Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends

5. Global Autoimmune Disease Drug Market, by Indication
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Diabetes Mellitus Type 1
5.4. Multiple Sclerosis
5.5. Rare Diseases
5.6. Rheumatic Diseases

6. Global Autoimmune Disease Drug Market, by Drug Class
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Anti-inflammatory
6.4. Antihyperglycemic
6.5. Immunosuppressants
6.6. Interferons
6.7. NSAIDs

7. Global Autoimmune Disease Drug Market, by Distribution
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hospital Pharmacies
7.4. Online Stores
7.5. Retail Pharmacies

8. Global Autoimmune Disease Drug Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom

9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix for Global Autoimmune Disease Drug Market
9.2. Market Vendor Ranking Analysis for Global Autoimmune Disease Drug Market
9.3. Competitive News Feed Analysis for Global Autoimmune Disease Drug Market

10. Company Usability Profiles
10.1. Abbott Laboratories
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Amgen Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Bristol-Myers Squibb Company
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. F. Hoffmann-La Roche AG
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Johnson & Johnson
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. AstraZeneca plc.
10.7. Novartis AG
10.8. Pfizer Inc.

11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details